CYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With Ifosfamide

Clinical trial NCT00514345 · UNKNOWN

Trial details

NCT number: NCT00514345
Sponsor: Children's Cancer and Leukaemia Group
Status: UNKNOWN
Study type: OBSERVATIONAL

Chemotherapeutic Agent Toxicity Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific

Start date: 2007-07-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.